mAbs

Kaydedildi:
Detaylı Bibliyografya
Materyal Türü: Online
Dil:EN
Baskı/Yayın Bilgisi: Taylor & Francis Group 2021
Konular:
Online Erişim:1942-0870
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
_version_ 1869535502270464000
collection Directory of Open Access
format Online
id oai:doaj.orgir-journal:35d219da09c84009a1af37a5f3f7bc9e
institution Directory of Open Access
language EN
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Taylor & Francis Group
publisherStr Taylor & Francis Group
record_format ojs
spelling oai:doaj.orgir-journal:35d219da09c84009a1af37a5f3f7bc9e2026-01-15T10:38:32ZmAbs1942-08701942-0862https://doaj.org/toc/1942-0870ENCC BYCC BY-NCTaylor & Francis Grouphttps://www.tandfonline.com/journals/kmabhttps://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=kmab20https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=kmab202021-05-10T13:02:02Zjournalimmunologyantibodiescancerantibody therapeuticsantibody engineeringTherapeutics. PharmacologyRM1-950Immunologic diseases. AllergyRC581-607
spellingShingle immunology
antibodies
cancer
antibody therapeutics
antibody engineering
Therapeutics. Pharmacology
RM1-950
Immunologic diseases. Allergy
RC581-607
mAbs
title mAbs
title_full mAbs
title_fullStr mAbs
title_full_unstemmed mAbs
title_short mAbs
title_sort mabs
topic immunology
antibodies
cancer
antibody therapeutics
antibody engineering
Therapeutics. Pharmacology
RM1-950
Immunologic diseases. Allergy
RC581-607
topic_facet immunology
antibodies
cancer
antibody therapeutics
antibody engineering
Therapeutics. Pharmacology
RM1-950
Immunologic diseases. Allergy
RC581-607
url 1942-0870